A New Immunotherapy Option for Follicular Lymphoma
The FDA granted accelerated approval to a CAR T-cell therapy for certain adult patients with follicular lymphoma. The U.S....
Progress Against Cancer
The FDA granted accelerated approval to a CAR T-cell therapy for certain adult patients with follicular lymphoma. The U.S....
The FDA approved a new regimen that includes a molecularly targeted therapeutic for some older leukemia patients not eligible...
The FDA approved the chemotherapeutic azacitidine for patients with juvenile myelomonocytic leukemia The U.S. Food and Drug Administration (FDA)...
The FDA has granted full approval to an antibody-drug conjugate for certain patients with breast cancer. The U.S. Food...
The FDA approved the cellular immunotherapy axicabtagene ciloleucel for second-line treatment of patients with large B-cell lymphoma. The U.S....
The FDA has approved a radioactive compound and companion diagnostic test for patients with advanced prostate cancer. The U.S....
The FDA approved pembrolizumab for certain patients with advanced endometrial cancer with DNA repair defects The U.S. Food and...
The FDA approved nivolumab and relatlimab-rmbw (Opdualag) for some patients with advanced melanoma The U.S. Food and Drug...
The FDA approved olaparib for patients with breast cancer who have inherited BRCA mutations and have received prior neoadjuvant...
The FDA approved nivolumab in combination with chemotherapy for use before surgery in certain patients with non-small cell lung...